Qin E, Guilz N. Using CRISPR-Cas9 In Human Fetuses to Prevent Trisomy 16 and Trisomy 22 Induced Miscarriages. J Stud Res [Internet]. 2022Nov.30 [cited 2024Nov.22];11(4). Available from: https://www.jsr.org/hs/index.php/path/article/view/3859